These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 8899756
1. The effects of heparin flush on patency of the Groshong catheter: a pilot study. Mayo DJ, Horne MK, Summers BL, Pearson DC, Helsabeck CB. Oncol Nurs Forum; 1996 Oct; 23(9):1401-5. PubMed ID: 8899756 [Abstract] [Full Text] [Related]
4. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis. Kaneko Y, Iwano M, Yoshida H, Kosuge M, Ito S, Narita I, Gejyo F, Suzuki M. Blood Purif; 2004 Oct; 22(5):473-9. PubMed ID: 15523172 [Abstract] [Full Text] [Related]
5. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter. Kulkarni M, Elsner C, Ouellet D, Zeldin R. Can J Surg; 1994 Feb; 37(1):37-42. PubMed ID: 8306218 [Abstract] [Full Text] [Related]
6. Comparison of heparinized and nonheparinized solutions for maintaining patency of arterial and pulmonary artery catheters. Zevola DR, Dioso J, Moggio R. Am J Crit Care; 1997 Jan; 6(1):52-5. PubMed ID: 9116787 [Abstract] [Full Text] [Related]
7. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Schallom ME, Prentice D, Sona C, Micek ST, Skrupky LP. Crit Care Med; 2012 Jun; 40(6):1820-6. PubMed ID: 22488006 [Abstract] [Full Text] [Related]
8. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Bertoglio S, Solari N, Meszaros P, Vassallo F, Bonvento M, Pastorino S, Bruzzi P. Cancer Nurs; 2012 Jun; 35(4):E35-42. PubMed ID: 22228390 [Abstract] [Full Text] [Related]
9. A randomized, prospective trial of standard Hickman compared with Groshong central venous catheters in pediatric oncology patients. Warner BW, Haygood MM, Davies SL, Hennies GA. J Am Coll Surg; 1996 Aug; 183(2):140-4. PubMed ID: 8696545 [Abstract] [Full Text] [Related]
14. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. Infect Control Hosp Epidemiol; 2005 Jun; 26(6):520-4. PubMed ID: 16018426 [Abstract] [Full Text] [Related]
15. Evaluation of the effects of heparinized and nonheparinized flush solutions on the patency of arterial pressure monitoring lines: the AACN Thunder Project. By the American Association of Critical-Care Nurses. Am J Crit Care; 1993 Jan; 2(1):3-15. PubMed ID: 8353575 [Abstract] [Full Text] [Related]
16. Nurse and patient satisfaction with three types of venous access devices. Dearborn P, De Muth JS, Requarth AB, Ward SE. Oncol Nurs Forum; 1997 Jan; 24(1 Suppl):34-40. PubMed ID: 9010863 [Abstract] [Full Text] [Related]
20. Comparison of normal or heparinised saline flushing on function of arterial lines. Whitta RK, Hall KF, Bennetts TM, Welman L, Rawlins P. Crit Care Resusc; 2006 Sep; 8(3):205-8. PubMed ID: 16930104 [Abstract] [Full Text] [Related] Page: [Next] [New Search]